Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency


Creative Commons License

Aydin S. E., Freeman A. F., Al-Herz W., Al-Mousa H. A., Arnaout R. K., Aydin R. C., ...Daha Fazla

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, cilt.7, sa.3, ss.848-855, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.jaip.2018.10.035
  • Dergi Adı: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.848-855
  • Anahtar Kelimeler: DOCK8 deficiency, HSCT, Combined immunodeficiency, DEDICATOR, IMMUNODEFICIENCY, PHENOTYPE, ADULTS, GRAFT
  • Ankara Üniversitesi Adresli: Evet

Özet

BACKGROUND: Biallelic variations in the dedicator of cytokinesis 8 (DOCK8) gene cause a combined immunodeficiency with eczema, recurrent bacterial and viral infections, and malignancy. Natural disease outcome is dismal, but allogeneic hematopoietic stem cell transplantation (HSCT) can cure the disease.